HGH Fragment 176-191
Also known as · AOD fragment · Frag 176-191
to clear
How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.
The C-terminal fat-loss fragment of growth hormone, designed to drive lipolysis without GH's growth or glucose effects.
Stimulates lipolysis and inhibits lipogenesis via beta-3 adrenergic pathways, largely independent of IGF-1.
250–500 mcg subQ, 1–2× daily, often fasted.
Reconstituted: refrigerated, ~30 days.
This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.
CJC-1295
A long-acting GHRH analog (with DAC) that stimulates pulsatile growth-hormone release. Often stacked with Ipamorelin.
Ipamorelin
A selective ghrelin-receptor agonist that triggers GH release without raising cortisol or prolactin. Cleaner profile than older GHRPs.
Sermorelin
A GHRH (1-29) analog historically prescribed to assess and stimulate growth-hormone secretion. Short-acting and biomimetic.